StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

DL-leucine → HCID 7237625, Verbindung

HRID 2083830
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 2083830
[CH2:1]([O:8][C:9]([NH:11][C@@H:12]([C:17]([OH:19])=O)[CH2:13][CH:14]([CH3:16])[CH3:15])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.NC(C(O)=O)CC(C)C.N[C@H](C(O)=O)CC(C)C.C(OC(N[C@H](C(O)=O)CC(C)C)=O)C1C=CC=CC=1.Cl.[CH3:58][O:59][C:60](=[O:67])[C@H:61]([CH2:63][CH:64]([CH3:66])[CH3:65])[NH2:62].ON1C2C=CC=CC=2N=N1.C1(N=C=NC2CCCCC2)CCCCC1>C(N(CC)CC)C.CN(C)C=O>[CH3:58][O:59][C:60](=[O:67])[C@H:61]([CH2:63][CH:64]([CH3:66])[CH3:65])[NH:62][C:17](=[O:19])[C@@H:12]([CH2:13][CH:14]([CH3:15])[CH3:16])[NH:11][C:9]([O:8][CH2:1][C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1)=[O:10]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

10

Edukt 7

HCID 857DL-leucineHCID 6106L-LeucineHCID 10868DicyclohexylcarbodiimideHCID 74840Leucine, N-carboxy-, N-benzyl ester, L-HCID 757711-HydroxybenzotriazoleHCID 2723695Leucine methyl ester hydrochlorideHCID 7000099
N-Cbz-D-leucine

Produkt 1

HCID 7237625HCID 7237625, Verbindung

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 8471TriethylamineLösungsmittel

Versuchsvorschrift

A solution of 2.65 g. of Nα -benzyloxycarbonyl-D-leucine [This material is prepared by the same procedure as used by Grassman and Wunsch, Ber. 91, 462 (1968) for the DL-leucine and for the L-leucine see Losse and Demuth, Ber. 94, 1762 (1961). The material is an oil as described for the Nα -benzyloxycarbonyl-L-leucine enantiomer. See also Farthing, J. Chem. Soc. 1950, 3213 and Bergmann, J. Biol. Chem., 115, 593 (1936).] in 50 ml. of dimethylformamide is treated with 1.98 g. of L-leucine methyl ester hydrochloride and cooled in an ice bath. The solution is treated with 1.4 ml. of triethylamine, then with 1.5 g. of 1-hydroxybenztriazole, and finally with 2.26 g. of dicyclohexylcarbodiimide. The reaction is stirred overnight with initial ice bath cooling and gradual warming to room temperature, and then an additional 24 hours at room temperature. The mixture is filtered and the filtrate evaporated. The residue is dissolved in ethyl acetate and the solution washed with 1N hydrochloric acid, saturated sodium chloride solution, 5% sodium bicarbonate solution and again with saturated sodium chloride solution. The ethyl acetate solution is separated and dried over magnesium sulfate, filtered and evaporated. The residue crystallizes and is recrystallized from isopropyl ether; [α]D23 -5.3° (c 2.06, methanol), m.p. 80°-82° C.

Aufarbeitung

  1. additionThe solution is treated with 1.4 ml
  2. temperaturecooling
  3. customan additional 24 hours
  4. customat room temperature
  5. filtrationThe mixture is filtered
  6. customthe filtrate evaporated
  7. dissolutionThe residue is dissolved in ethyl acetate
  8. washthe solution washed with 1N hydrochloric acid, saturated sodium chloride solution, 5% sodium bicarbonate solution and again with saturated sodium chloride solution
  9. customThe ethyl acetate solution is separated
  10. dry with materialdried over magnesium sulfate
  11. filtrationfiltered
  12. customevaporated
  13. customThe residue crystallizes
  14. customis recrystallized from isopropyl ether

Quellen und Nachweise

ORD-Eintrag
ord-8a5909307e68424b82bb2850a911ed24
Quelldatensatz
uspto-grants-1978_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US04086219

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion